New findings may have significant implications for the growing
generics drugs industry, by challenging previous assumptions that
all formulations of the same active pharmaceutical ingredient (API)
are therapeutically equivalent.
AssurX have launched a software process for document control, which
will enable pharmaceutical manufacturing companies to streamline
their approach to monitoring safety issues and overall quality
Penn Pharmaceutical Services has reported strong sales figures for
the fifth consecutive year, with a key driver of recent growth
being attributed to a boom in contract manufacturing as well as
small-scale commercial batches.
Cambrex has recorded a gain in the third quarter of this year, with
growth in its Bioproducts and Human Health segments. The company's
troublesome BioPharma division continues to underperform,
indicative of a market for outsourced...
Cardinal Health reported a varied first quarter, with sales and
income receiving substantial gains due to across-the-board
improvement in pharmaceutical distribution, medical products and
services and clinical technologies.
Arsenal Capital Partners has acquired a majority stake in Reilly
Industries for €209 million and Velsicol Chemical for an
undisclosed fee. The purchases continue a rich vein of activity for
the private equity firm, which now hold...